Introduction

This page provides a comprehensive analysis of the known insider trading history of J Michael Cline. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

See Highest Ranking Insiders
Companies with Reported Insider Positions

The SEC filings indicate J Michael Cline has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:ACCD / Accolade, Inc. Director 1,381,255
US:AH / Director, 10% Owner 3,320
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by J Michael Cline. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Trading History

This table shows the complete list of insider trades made by J Michael Cline as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change		 Share
Price		 Tran
Value		 Remaining
Value
2021-02-01 2021-01-28 4 ACCD Accolade, Inc.
Common Stock 		J - Other 775,105 1,381,255 127.87
2021-02-01 2021-01-28 4 ACCD Accolade, Inc.
Common Stock 		J - Other -4,499,447 0 -100.00
2021-02-01 2021-01-28 4 ACCD Accolade, Inc.
Common Stock 		J - Other 12,431 606,150 2.09
2021-02-01 2021-01-28 4 ACCD Accolade, Inc.
Common Stock 		J - Other -3,293,683 0 -100.00
2021-02-01 2021-01-28 4 ACCD Accolade, Inc.
Common Stock 		J - Other 303,650 593,719 104.68
2021-02-01 2021-01-28 4 ACCD Accolade, Inc.
Common Stock 		J - Other -1,076,796 0 -100.00
2021-02-01 2021-01-28 4 ACCD Accolade, Inc.
Common Stock 		J - Other 289,746 290,069 89,704.64
2021-02-01 2021-01-28 4 ACCD Accolade, Inc.
Common Stock 		J - Other -1,130,221 0 -100.00
2021-02-01 2021-01-28 4 ACCD Accolade, Inc.
Common Stock 		J - Other 323 323
2021-02-01 2021-01-28 4 ACCD Accolade, Inc.
Common Stock 		J - Other -128,961 0 -100.00
2020-07-08 2020-07-07 4 ACCD Accolade, Inc.
Series C Preferred Stock 		C - Conversion -179,553 0 -100.00
2020-07-08 2020-07-07 4 ACCD Accolade, Inc.
Series B Preferred Stock 		C - Conversion -919,528 0 -100.00
2020-07-08 2020-07-07 4 ACCD Accolade, Inc.
Series A-2 Preferred Stock 		C - Conversion -1,136,563 0 -100.00
2020-07-08 2020-07-07 4 ACCD Accolade, Inc.
Series A-1 Preferred Stock 		C - Conversion -1,590,905 0 -100.00
2020-07-08 2020-07-07 4 ACCD Accolade, Inc.
Series C Preferred Stock 		C - Conversion -131,436 0 -100.00
2020-07-08 2020-07-07 4 ACCD Accolade, Inc.
Series B Preferred Stock 		C - Conversion -673,113 0 -100.00
2020-07-08 2020-07-07 4 ACCD Accolade, Inc.
Series A-2 Preferred Stock 		C - Conversion -831,986 0 -100.00
2020-07-08 2020-07-07 4 ACCD Accolade, Inc.
Series A-1 Preferred Stock 		C - Conversion -1,164,574 0 -100.00
2020-07-08 2020-07-07 4 ACCD Accolade, Inc.
Series C Preferred Stock 		C - Conversion -42,970 0 -100.00
2020-07-08 2020-07-07 4 ACCD Accolade, Inc.
Series B Preferred Stock 		C - Conversion -220,059 0 -100.00
2020-07-08 2020-07-07 4 ACCD Accolade, Inc.
Series A-2 Preferred Stock 		C - Conversion -271,999 0 -100.00
2020-07-08 2020-07-07 4 ACCD Accolade, Inc.
Series A-1 Preferred Stock 		C - Conversion -380,732 0 -100.00
2020-07-08 2020-07-07 4 ACCD Accolade, Inc.
Series C Preferred Stock 		C - Conversion -45,061 0 -100.00
2020-07-08 2020-07-07 4 ACCD Accolade, Inc.
Series B Preferred Stock 		C - Conversion -230,215 0 -100.00
2020-07-08 2020-07-07 4 ACCD Accolade, Inc.
Series A-2 Preferred Stock 		C - Conversion -306,871 0 -100.00
2020-07-08 2020-07-07 4 ACCD Accolade, Inc.
Series A-1 Preferred Stock 		C - Conversion -378,186 0 -100.00
2020-07-08 2020-07-07 4 ACCD Accolade, Inc.
Series C Preferred Stock 		C - Conversion -5,146 0 -100.00
2020-07-08 2020-07-07 4 ACCD Accolade, Inc.
Series B Preferred Stock 		C - Conversion -26,356 0 -100.00
2020-07-08 2020-07-07 4 ACCD Accolade, Inc.
Series A-2 Preferred Stock 		C - Conversion -32,575 0 -100.00
2020-07-08 2020-07-07 4 ACCD Accolade, Inc.
Series A-1 Preferred Stock 		C - Conversion -45,598 0 -100.00
2020-07-08 2020-07-07 4 ACCD Accolade, Inc.
Common Stock 		C - Conversion 3 4,499,447 0.00
2020-07-08 2020-07-07 4 ACCD Accolade, Inc.
Common Stock 		C - Conversion 274,586 4,499,444 6.50
2020-07-08 2020-07-07 4 ACCD Accolade, Inc.
Common Stock 		C - Conversion 1,094,020 4,224,858 34.94
2020-07-08 2020-07-07 4 ACCD Accolade, Inc.
Common Stock 		C - Conversion 1,336,804 3,130,838 74.51
2020-07-08 2020-07-07 4 ACCD Accolade, Inc.
Common Stock 		C - Conversion 1,794,034 1,794,034
2020-07-08 2020-07-07 4 ACCD Accolade, Inc.
Common Stock 		C - Conversion 2 3,293,683 0.00
2020-07-08 2020-07-07 4 ACCD Accolade, Inc.
Common Stock 		C - Conversion 201,002 3,293,681 6.50
2020-07-08 2020-07-07 4 ACCD Accolade, Inc.
Common Stock 		C - Conversion 800,845 3,092,679 34.94
2020-07-08 2020-07-07 4 ACCD Accolade, Inc.
Common Stock 		C - Conversion 978,566 2,291,834 74.51
2020-07-08 2020-07-07 4 ACCD Accolade, Inc.
Common Stock 		C - Conversion 1,313,268 1,313,268
2020-07-08 2020-07-07 4 ACCD Accolade, Inc.
Common Stock 		C - Conversion 1 1,076,796 0.00
2020-07-08 2020-07-07 4 ACCD Accolade, Inc.
Common Stock 		C - Conversion 1 1,076,796 0.00
2020-07-08 2020-07-07 4 ACCD Accolade, Inc.
Common Stock 		C - Conversion 1 1,076,796 0.00
2020-07-08 2020-07-07 4 ACCD Accolade, Inc.
Common Stock 		C - Conversion 65,713 1,076,795 6.50
2020-07-08 2020-07-07 4 ACCD Accolade, Inc.
Common Stock 		C - Conversion 261,818 1,011,082 34.94
2020-07-08 2020-07-07 4 ACCD Accolade, Inc.
Common Stock 		C - Conversion 319,920 749,264 74.51
2020-07-08 2020-07-07 4 ACCD Accolade, Inc.
Common Stock 		C - Conversion 429,344 429,344
2020-07-08 2020-07-07 4 ACCD Accolade, Inc.
Common Stock 		C - Conversion 68,910 1,130,220 6.49
2020-07-08 2020-07-07 4 ACCD Accolade, Inc.
Common Stock 		C - Conversion 273,901 1,061,310 34.79
2020-07-08 2020-07-07 4 ACCD Accolade, Inc.
Common Stock 		C - Conversion 360,936 787,409 84.63
2020-07-08 2020-07-07 4 ACCD Accolade, Inc.
Common Stock 		C - Conversion 426,473 426,473
2020-07-08 2020-07-07 4 ACCD Accolade, Inc.
Common Stock 		C - Conversion 7,869 128,960 6.50
2020-07-08 2020-07-07 4 ACCD Accolade, Inc.
Common Stock 		C - Conversion 31,357 121,091 34.94
2020-07-08 2020-07-07 4 ACCD Accolade, Inc.
Common Stock 		C - Conversion 38,314 89,734 74.51
2020-07-08 2020-07-07 4 ACCD Accolade, Inc.
Common Stock 		C - Conversion 51,420 51,420
2013-10-03 2013-10-01 4 AH Accretive Health, Inc.
Director Stock Option (right to buy) 		A - Award 3,320 3,320 4.52 15,006 15,006
2013-07-03 2013-07-01 4 AH Accretive Health, Inc.
Director Stock Option (right to buy) 		A - Award 2,732 2,732 5.49 14,999 14,999
2013-04-03 2013-04-01 4 AH Accretive Health, Inc.
Director Stock Option (right to buy) 		A - Award 4,018 4,018 4.98 20,010 20,010
2013-01-03 2013-01-02 4 AH Accretive Health, Inc.
Director Stock Option (right to buy) 		A - Award 3,519 3,519 5.68 19,988 19,988
2012-12-06 2012-12-05 4 AH Accretive Health, Inc.
Common Stock 		J - Other -8,215 19,045 -30.14
2012-12-06 2012-12-03 4 AH Accretive Health, Inc.
Common Stock 		G - Gift -50,000 7,216,016 -0.69
2012-10-03 2012-10-01 4 AH Accretive Health, Inc.
Director Stock Option (right to buy) 		A - Award 3,606 3,606 5.55 20,013 20,013
2012-07-05 2012-07-02 4 AH Accretive Health, Inc.
Director Stock Option (right to buy) 		A - Award 3,623 3,623 5.52 19,999 19,999
2012-04-04 2012-04-02 4 AH Accretive Health, Inc.
Director Stock Option (right to buy) 		A - Award 2,036 2,036 9.82 19,994 19,994
2012-03-06 2012-03-02 4 AH Accretive Health, Inc.
Common Stock 		J - Other -7,883 27,260 -22.43
2012-01-05 2012-01-03 4 AH Accretive Health, Inc.
Director Stock Option (right to buy) 		A - Award 1,760 1,760 11.36 19,994 19,994
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)